We obtained plasma samples from 139 extensively diagnosed PACG patients and 149 controls. Our control group was carefully selected in terms of age, sex, ethnicity, smoking status and other diseases (diabetes, hypertension and hypercholesterolemia) which could influence TAS levels. The two groups were matching for those factors and this was of particular importance, as those factors can influence the TAS level, and thus can affect the results independent of the glaucoma status [9].
We then proceeded with measurement of TAS levels in both groups. Although TAS level was higher in the Patient group compared to the controls, this difference was not statistically significant. This was in contrast to our previous results where TAS level was decreased in a group of patients with psueduoexfoliation glaucoma (PEG) [10]. This may indicate that oxidative stress represented indirectly by the TAS levels, play a bigger role in case of PEG than for PACG. Oxidative stress which is linked strongly to mitochondrial abnormalities (such as decreased mitochondrial respiration, mtDNA mutations and mtDNA copy number alterations) were demonstrated in POAG and PEG cases but not in PACG, thus enforcing our current observation that oxidative stress may play a minor role in PACG development compared to other types of glaucoma. It is also possible that TAS decreased levels are more linked to particular clinical indices important for PACG rather than for the disease as a whole. Optic nerve injury in PACG has been attributed primarily to elevated IOP caused by anatomic changes in the anterior [11] and posterior [12] globe, in contrast with the molecular and biochemical abnormalities suspected in POAG [13]. Perhaps for this reason, the role of oxidative stress in PACG has received limited attention demonstrated by the fact that this is the first study to investigate the TAS level in PACG patients. This is despite reports that PACG may be present in 3.9 million people around the world [14].
When we investigated the potential correlation between TAS and glaucoma indices, we found a statistically significant inverse correlation between TAS and IOP. This is interesting, since optic nerve injury in PACG is attributed primarily to elevated IOP.
The literature shows inconsistent findings regarding antioxidant activity in serum and aqueous humor in glaucoma patients. Yildrim and colleagues studied 40 patients with glaucoma and found no association between glaucoma and systemic myeloperoxidase or catalase enzyme activity [15]. Yuki and colleagues found an increase in the serum total antioxidant status of patients with normal-tension glaucoma compared to matching controls [16]. In contrast, Sorkhabi et al. showed that the serum level of TAS in patients with primary open angle glaucoma was lower than that of cataract controls [17]. Gherghel and colleagues [18] concluded that glaucoma patients exhibit low levels of circulating glutathione, suggesting compromised oxidative defense. The only study of total reactive antioxidant potential (TRAP) and antioxidant enzymes in aqueous humor was performed by Ferreira and colleagues, and showed significantly decreased TRAP values and increased superoxide dismutase and glutathione peroxidase activity in glaucoma patients [8]. The antioxidant defense system comprises a variety of molecules: enzymes such as superoxide dismutase, catalase, or glutathione peroxidase, that are capable of catalytically removing free radicals and other reactive species; proteins, such as transferrins or haptoglobins, that minimize the availability of pro-oxidants such as iron or copper ions; heat shock proteins that protect biomolecules against damage; and low-molecular mass molecules such as α-tocopherol, ascorbic acid, or glutathione capable of scavenging ROS and RNS. The composition of antioxidant defenses differs from tissue to tissue and from cell type to cell type [19]. All of these compounds and more exist in human plasma. Antioxidants that can be found in human plasma vary, and can be summarized mainly in the following compounds: albumin, ceruloplasmin, ferritin, ascorbic acid, α-tocopherol, β-carotene, lycopene, reduced glutathione, bilirubin, glutathione peroxidase, uric acid, catalase, and superoxide dismutase [20]. The exact mechanism of how oxidative stress contributes to glaucoma pathogenesis remains speculative. Glaucomatous optic neuropathy implies loss of retinal ganglion cells, including their axons, and a major tissue remodeling, especially in the optic nerve head. Although increased intraocular pressure is a major risk factor for glaucomatous optic neuropathy, there is little doubt that other factors such as ocular blood flow play a role as well [21]. Mechanisms leading to glaucomatous optic neuropathy are not yet clearly understood. There is, however, increasing evidence that both an activation of glial cells and oxidative stress in the axons may play an important role [22]. Glial cells may be activated by mechanical stress via activation of the epidermal growth-factor receptor, or by ischemic stress via an increase in endothelin.
We have to acknowledge the following limitations in our study. First, our total antioxidants method employed here measured the total antioxidant status and not a particular compound or byproduct. A detailed examination of those individual antioxidants separately might help to identify a particular antioxidant that is severely decreased and thus provide a new therapeutic agent for glaucoma. Second, the systemic decrease in antioxidants might not reflect the exact situation at the anterior segment structures, which are exposed to free radicals and thus more directly involved in the formation and development of glaucoma through the oxidative stress mechanism.
Since measurement of TAS levels in the plasma is usually straightforward and relatively not expensive, TAS level can be used routinely as a marker for PACG especially if our results are confirmed in different ethnicities and larger cohorts.